Context Therapeutics Inc. (CNTX) AI Dilution Summary

Cash was $42,990,371 at 2026-06-30 against estimated monthly burn of $2,339,912, and a $2,000,000 payment to BioAtla followed on 2026-08-01. The company funds itself through an active ATM program with Leerink Partners LLC, authorised to $75,000,000, under which 14,705,882 shares were sold since the program began through 2026-06-30; sales after 2026-06-30 are not yet reported. Dilution here is driven primarily by that ATM's $75,000,000 of remaining capacity.